Canadian Journal of Gastroenterology and Hepatology

Research Article

Seroprevalence of Antitransglutaminase and Antiendomysium Antibodies in Adult Colombian Blood Bank Donors

Table 2

Celiac disease prevalence studies performed in Latin America.
StudyRefCountryNo.GliadinTTGEMABiopsySeroprevalence (%)Prevalence (%)
IgAIgGIgAIgGIgAIgG
Gomez et al., 2001[30]Argentina2,000++−−+++0.500.59
Mora et al., 2010[31]Argentina2,219−−+−+−+1.301.26
Vázquez et al., 2015[21]Argentina144−++−+−−2.70NP
Alencar et al., 2012[18]Brazil4,000−−+−+−+0.600.35
Almeida et al., 2013[19]Brazil946−−+−+−−0.95NP
Almeida et al., 2012[20]Brazil840−−−−+−−0.00NP
Gandolfi et al., 2000[32]Brazil2,045++−−+++3.030.15
Melo et al., 2006[33]Brazil3,000−−+−+−+0.500.33
Oliveira et al., 2007[34]Brazil3,000−−+−−−+1.500.47
Pereira et al., 2006[26]Brazil2,086−−+−+−+0.280.24
Utiyama et al., 2010[27]Brazil321−−−−++−0.00NP
Parra-Medina et al., 2015[28]Colombia260G1G1G1, G2G1G2−−2.69NP
Galván et al., 2009[29]Cuba200−−++−−+0.500.50
Remes-Troche et al., 2006[22]Mexico1,009−−+−−−−2.67NP
Ref: reference; No.: study population; gliadin: antigliadin antibody testing; TTG: anti-TTG antibody testing; EMA: anti-EMA antibody testing; G1: samples from the northwestern region of Colombia; G2: samples from the central area of Colombia. (+): done; (−): not done; NP: not provided. The samples were from children; the samples were from the Amerindian population; the samples were from the elderly; the samples were from the Afro-descendant population.